Item 9 Labs Corp (INLB)
0.0001
0.00 (0.00%)
USD |
OTCM |
May 06, 12:13
Item 9 Labs Net Income (TTM): -31.03M for June 30, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2023 | -31.03M |
| March 31, 2023 | -30.59M |
| December 31, 2022 | -31.06M |
| September 30, 2022 | -31.14M |
| June 30, 2022 | -21.74M |
| March 31, 2022 | -17.10M |
| December 31, 2021 | -13.18M |
| September 30, 2021 | -10.91M |
| June 30, 2021 | -8.999M |
| March 31, 2021 | -9.772M |
| December 31, 2020 | -11.40M |
| September 30, 2020 | -12.27M |
| June 30, 2020 | -12.90M |
| March 31, 2020 | -12.14M |
| December 31, 2019 | -11.45M |
| September 30, 2019 | -9.825M |
| June 30, 2019 | -2.417M |
| March 31, 2019 | -1.911M |
| December 31, 2018 | -1.055M |
| September 30, 2018 | -1.702M |
| June 30, 2018 | -1.424M |
| March 31, 2018 | -1.090M |
| December 31, 2017 | -1.149M |
| September 30, 2017 | -0.2666M |
| Date | Value |
|---|---|
| June 30, 2017 | -0.8851M |
| March 31, 2017 | -1.280M |
| December 31, 2016 | -2.822M |
| September 30, 2016 | -3.126M |
| June 30, 2016 | -4.407M |
| March 31, 2016 | -4.844M |
| December 31, 2015 | -4.214M |
| September 30, 2015 | -4.741M |
| June 30, 2015 | -3.465M |
| March 31, 2015 | -3.282M |
| December 31, 2014 | -16.84M |
| September 30, 2014 | -17.08M |
| June 30, 2014 | -18.16M |
| March 31, 2014 | -18.22M |
| December 31, 2013 | -4.110M |
| September 30, 2013 | -3.325M |
| June 30, 2013 | -2.106M |
| March 31, 2013 | -3.656M |
| December 31, 2012 | -3.220M |
| June 30, 2012 | -2.848M |
| March 31, 2012 | -3.156M |
| December 31, 2011 | -1.393M |
| September 30, 2011 | -1.389M |
| June 30, 2011 | -1.390M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-31.14M
Minimum
Sep 2022
-2.417M
Maximum
Jun 2019
-16.35M
Average
-12.27M
Median
Sep 2020
Net Income (TTM) Benchmarks
| Humanigen Inc | -53.63M |
| Cantabio Pharmaceuticals Inc | -1.543M |
| Affymax Inc | -- |
| RVL Pharmaceuticals PLC | -68.27M |
| Scopus BioPharma Inc | -8.696M |